Career
What's Your Next Step at Legend Biotech?
7 min read
Charlotte Kluit did not set out to build a career in the biopharmaceutical industry. After studying commercial economics at HAN University of Applied Sciences, she was looking for an industry where she could put her marketing skills to use. Pharma caught her attention because of its connection to patients and the pace of innovation.

Charlotte Kluit, Kite Pharma, Director CAR T-Cell Therapy BU BeNeLux and Ambassador of TOPX Network Photo by:
By Jayashree Jayachandran for TOPX Network
More than three decades later, she has worked across various roles at Servier, J&J, Roche and MSD, and now leads Kite’s CAR T-cell therapy team across Belgium, the Netherlands and Luxembourg (Benelux). During this period, she obtained an MSc in Management & Organisation and completed many in-company leadership training programmes.
Along the way, her idea of leadership has shifted more and more towards people: understanding them, building relationships and bringing different teams together around one shared goal, getting innovative treatments to the patients who need them.
Like many professionals, Charlotte got her first leadership role because she was good at her job.
“I thought, I’m an expert, so I can help bring others to that level,” she recalls. “I learned pretty quickly that has nothing to do with leadership.”
“You can be the expert, but that’s totally different from being a leader.”
She gradually learned to adjust her management style to the individual. Some colleagues need a challenge, others respond better to empowerment, and some prefer clear instructions and more structure.
That last approach does not come naturally to her. Charlotte prefers giving people the freedom to decide how they carry out their work, but she recognises that not everyone appreciates the same degree of independence. Her solution is to make sure expectations are clear from the beginning and that everyone understands the intended outcome.
Moving from traditional pharmaceuticals into CAR T-cell therapy brought a different set of personal leadership responsibilities. Each treatment is manufactured using a patient’s own cells, so the process depends on close coordination between teams from various departments and the hospitals qualified to use this treatment. There is no stock to fall back on.
Relationships from her previous roles proved particularly useful. Charlotte had made a point of getting to know the people involved in the process, which gave her a better understanding of the operational side of the business.
“It concerns lives of patients, so you need strong collaboration and a team around delivering the therapy for the patient,” she says.
Charlotte tries to understand the perspective of the person she is dealing with and to frame requests in a way that works for both sides. She also makes time for conversations before problems arise. Knowing people personally, she says, makes a difference when an urgent situation requires everyone to work together.
Getting a therapy approved is only part of the journey. For many patients, reimbursement remains a significant barrier to innovative treatments.
Charlotte typically becomes involved around a year before a product receives EMA approval. This approval does not guarantee availability in the Netherlands, though, and reimbursement decisions can take years, particularly for treatments targeting rare diseases.
She describes a therapy for a very rare disease that was approved by the EMA four years ago. The team in Belgium recently obtained reimbursement for this ultra-orphan indication after applying for the third time.
“We will always continue to fight for access to innovations for the patients who need them,” she says. “Whether it’s three times or four times, in the end it’s about succeeding.”
Communication matters just as much. She believes leaders should be transparent about what they know, acknowledge what they cannot yet share and maintain trust within their teams. The COVID pandemic reinforced this for her: focus on what can be controlled and be honest about what cannot.
Charlotte is candid about networking: she doesn’t consider herself good at it.
For years, she balanced a demanding full-time career with family life, children, a dog, sports and time with friends. When something urgent came up at work, evening networking events were often the first commitment to go.
“Women take a lot on their shoulders,” she says. She sees the balance becoming more equal for younger generations, while acknowledging how much women are capable of managing.
Her own approach to networking is small-scale. She reaches out to colleagues she does not yet know but expects to work with in the future. A short coffee or a ten-minute video call is often enough to establish a connection.
“That can be ten minutes,” she says, “but it allows people to get a picture of who you are. Because the next time, you’re in a complicated business meeting and there’s no time to show the other side of who you are.”
She also makes an effort to meet people beyond her immediate professional circle.
“I really try to mingle, and not only with the usual suspects, but also with people who may not always get all the attention.”
That includes conversations with receptionists, cleaning staff and colleagues from other departments. For Charlotte, these everyday interactions are as much a part of building relationships as formal networking.
Asked whether she has felt the need to work harder than men to prove herself, she says this has not been a particular challenge in her professional environment. Her manager and her manager’s manager are women, and around 60 percent of the Gilead Benelux leadership team is female.
The harder trade-offs have sometimes been at home, particularly missing moments at her children’s school. A supportive husband and shared family responsibilities have helped her manage both sides of her life.
For scientists considering a move into the biopharmaceutical industry, Charlotte’s advice is to be patient and open to different career paths.
Senior leadership positions require experience, and that takes time to build. A first role may not directly reflect someone’s academic background, but it can be a valuable introduction to how a company operates.
She gives the example of a dentist who joined her company about a year ago as an account manager. The role doesn’t draw directly on her dental training, but it gives her the chance to understand the business, develop commercial skills and learn how the organisation works.
When assessing candidates, Charlotte looks beyond academic qualifications and technical knowledge. Scientific expertise is important, especially as pharmaceutical products become more complex. But she also wants to understand how candidates communicate, connect with others and contribute to a team.
“There are things you can learn, and things you cannot learn. You have to have them in your system. It is often the mindset.”
She looks for curiosity, care, energy and the ability to build rapport. Existing team members take part in recruitment decisions because she wants new colleagues to connect with the people they will work alongside.
She also values diversity. Different backgrounds and experiences bring different perspectives, provided there is a shared foundation of values.
For those hoping to build an international career, Charlotte recommends being flexible early on. Roles in different functions or countries give a broader understanding of the business and can open up opportunities later. Her advice: take opportunities when they come and make the most of them, because consistent performance is what opens the next door.
One of Charlotte’s most memorable leadership lessons came from her first manager.
Early in her career, she was ambitious and kept her calendar packed with appointments and meetings, often running into the evenings. During a conversation about her schedule, her manager noticed one empty morning. He took his pencil and drew a cross through it.
That morning, she was to do nothing.
“If you only work, you become like a robot.”
At the time, the idea was hard to accept. Over time, she came to value having space to step back, reflect and recharge, whether that means a long walk with the dog or simply a morning without another commitment.
Today, Charlotte protects her personal time as carefully as her work schedule. She does not check emails on holiday, although her team can call or text if something genuinely urgent comes up.
“Things continue when I’m not there,” she says. “Sometimes a decision can also be taken a week later.”
Outside work, Charlotte enjoys sailing, hiking and winter sports with her family, along with dinner parties, conversations by the fireside and the theatre. She would like to read more, so she listens to audiobooks on the long evening drives to Brussels.
This article is an interview of the BiotechNews - TOPX Leading Ladies in Life Sciences series